{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:05:33Z","timestamp":1788260733167,"version":"build-2803163510"},"reference-count":60,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:p>The objectives of this study were to perform a systematic review of publications between 2010 and 2021 on the antibiotic resistance of <jats:italic>Pseudomonas aeruginosa<\/jats:italic> and <jats:italic>Acinetobacter baumannii<\/jats:italic> from urinary tract infections and to analyze changes over time in hospital urine cultures from 2016 through 2021. The literature was searched, and a retrospective cross\u2010sectional descriptive study was performed in the hospital. Out of 21\u2009838 positive urine cultures, 3.86% were due to <jats:italic>P.\u2009aeruginosa<\/jats:italic> and 0.44% were due to <jats:italic>A.\u2009baumannii<\/jats:italic>. For <jats:italic>P.\u2009aeruginosa<\/jats:italic>, lower resistance rates were observed to virtually all tested antibiotics than were obtained in the systematic review, and the present series of hospital samples showed an <jats:italic>in vitro<\/jats:italic> resistance rate &lt;10% to ceftazidime, cefepime, meropenem, piperacillin\u2010tazobactam, amikacin, tobramycin, and colistin. For <jats:italic>A.\u2009baumannii<\/jats:italic>, the resistance rates to almost all antibiotics were higher in the present series than in the systematic review, being lowest to colistin (10%). Both microorganisms show reduced <jats:italic>in vitro<\/jats:italic> susceptibility to some antibiotics during the years of the COVID\u201019 pandemic in comparison to previous years. In our setting, both piperacillin\u2010tazobactam and meropenem can be recommended for the empirical treatment of UTIs by <jats:italic>P.\u2009aeruginosa<\/jats:italic>, whereas only colistin can be recommended for UTIs by <jats:italic>A.\u2009baumannii<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/apm.13360","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T11:49:20Z","timestamp":1700135360000},"page":"100-111","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antibiotic resistances of <i>Pseudomonas aeruginosa<\/i> and <i>Acinetobacter baumannii<\/i> in urine cultures: experience in a hospital of Southeast Spain"],"prefix":"10.1111","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2796-4907","authenticated-orcid":false,"given":"Horacio","family":"Requena\u2010Cabello","sequence":"first","affiliation":[{"name":"Departamento de Microbiolog\u00eda, Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada) Universidad de Granada  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5185-3247","authenticated-orcid":false,"given":"Enrique","family":"Rodr\u00edguez\u2010Guerrero","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda, Hospital Virgen de las Nieves Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada)  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-9442","authenticated-orcid":false,"given":"Manuela","family":"Exp\u00f3sito\u2010Ruiz","sequence":"additional","affiliation":[{"name":"Departamento de Estad\u00edstica e Investigaci\u00f3n Operativa, Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada) Universidad de Granada  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5227-5167","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Navarro\u2010Mar\u00ed","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda, Hospital Virgen de las Nieves Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada)  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-9740","authenticated-orcid":false,"given":"Jose","family":"Gutierrez\u2010Fernandez","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda, Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada) Universidad de Granada  Granada Spain"},{"name":"Servicio de Microbiolog\u00eda, Hospital Virgen de las Nieves Instituto de Investigaci\u00f3n BioSanitaria de Granada (Ibs\u2010Granada)  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"1","key":"e_1_2_11_2_1","first-page":"39","article-title":"Urinary tract infections in inpatients: that challenge","volume":"30","author":"V\u00e1squez V","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.23938\/ASSN.0125"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux043"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/504477"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/529198"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg098"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S386641"},{"key":"e_1_2_11_9_1","first-page":"ciad42","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram\u2010negative infections","author":"Tamma PD","year":"2023","journal-title":"Clin Infect Dis"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.11.025"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1306.070064"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01732-10"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0395-y"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.087"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.025"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_2_11_18_1","first-page":"197","article-title":"Etiology of urinary tract infections in our health area and susceptibility profile of the most common uropathogens","volume":"74","author":"Artero\u2010L\u00f3pez J","year":"2021","journal-title":"Arch Esp Urol"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02874-20"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.02.052"},{"key":"e_1_2_11_22_1","first-page":"641","article-title":"Evaluation of the antimicrobial susceptibility profile of microorganisms isolated from urine in the region of Vale do Sousa and T\u00e2mega","volume":"23","author":"Martins F","year":"2010","journal-title":"Acta Med Port"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.056945-0"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.07.005"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.04.004"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2015.02.006"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.26610"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000742"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2019.09.017"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105887"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2019.10.018"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv043"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000376569"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2015.05.034"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2018.055"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz191"},{"key":"e_1_2_11_37_1","first-page":"E630","article-title":"Current antibiotic resistance trends of uropathogens in Central Europe: survey from a tertiary hospital urology department 2011\u20102019","volume":"9","author":"Hrbacek J","year":"2020","journal-title":"Antibiot Basel Switz"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.37201\/req\/019.2021"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-011-0026-y"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2017.03.002"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.09.008"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2014.901444"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000677"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030373"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1898"},{"key":"e_1_2_11_46_1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios.Resistencia bacteriana y COVID\u201019: recomendaciones del PRAN para el uso prudente de los antibi\u00f3ticos durante la pandemia [Internet].2020. Available from:https:\/\/www.aemps.gob.es\/informa\/resistencia\u2010bacteriana\u2010y\u2010covid\u201019\u2010recomendaciones\u2010del\u2010pran\u2010para\u2010el\u2010uso\u2010prudente\u2010de\u2010los\u2010antibioticos\u2010durante\u2010la\u2010pandemia\/"},{"key":"e_1_2_11_47_1","first-page":"681","article-title":"Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in North India","volume":"133","author":"Taneja N","year":"2011","journal-title":"Indian J Med Res [Internet]"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(12)70008-0"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2221-1691(13)60071-4"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.04.011"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2016.06.011"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.01.008"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2017.03.006"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000421"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2296-x"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13787"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2018.11.005"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01966"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2020.1201"},{"key":"e_1_2_11_60_1","first-page":"630","article-title":"Acinetobacter baumannii infections in hospitalized patients, treatment outcomes","volume":"10","author":"Alrahmany D","year":"2021","journal-title":"Antibiot Basel Switz"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.4103\/UA.UA_109_20"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.13360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:51:45Z","timestamp":1705549905000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.13360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1111\/apm.13360"],"URL":"https:\/\/doi.org\/10.1111\/apm.13360","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"2023-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}